Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Respiratory Syncytial Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04605159
What this trial is testing

A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 11,194
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808268
What this trial is testing

A Phase II Clinical Study to Evaluate the Efficacy and Safety of YKYY018 for Inhalation Solution

Who this might be right for
Respiratory Syncytial Virus (RSV)
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. 160
Early research (Phase 1)Looking for participantsNCT07516418
What this trial is testing

Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age

Who this might be right for
Respiratory Syncytial Virus (RSV)Influenza A(H5N1)
Sanofi 570
Not applicableNot Yet RecruitingNCT07235397
What this trial is testing

Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset

Who this might be right for
Respiratory Syncytial Virus Infections
Pfizer 1
Early research (Phase 1)Study completedNCT02491463
What this trial is testing

Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults

Who this might be right for
Respiratory Synctial Virus Infections
GlaxoSmithKline 73
Not applicableStudy completedNCT01075178
What this trial is testing

Retrospective Palivizumab Study in Children With Hemodynamically Significant Congenital Heart Disease

Who this might be right for
Severe Respiratory Syncytial Virus Infection
Abbott 2,036
Not applicableUnknownNCT05047549
What this trial is testing

Community-based RSV Surveillance in Infant Mortality: Minimally Invasive Tissue Sampling Study in Karachi, Pakistan

Who this might be right for
Respiratory Syncytial Virus (RSV)Infant DeathCommunity-Acquired Infections
Aga Khan University 150
Not applicableLooking for participantsNCT07358910
What this trial is testing

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Who this might be right for
DengueChikungunyaZika Virus Infection+55 more
Institut Pasteur du Cambodge 10,000
Early research (Phase 1)Study completedNCT02830932
What this trial is testing

Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)

Who this might be right for
Respiratory Syncytial Virus (RSV)
Vaxart 66
Not applicableLooking for participantsNCT07599449
What this trial is testing

Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France

Who this might be right for
Respiratory Tract Infections (RTI)Influenza -Like IllnessInfluenza+4 more
Institut National de la Santé Et de la Recherche Médicale, France 25,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT07289542
What this trial is testing

Phase II Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or Above

Who this might be right for
Respiratory Syncytial Virus
Suzhou Abogen Biosciences Co., Ltd. 420
Large-scale testing (Phase 3)Study completedNCT05330975
What this trial is testing

MRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 3,317
Testing effectiveness (Phase 2)UnknownNCT06344975
What this trial is testing

Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine STR-V003 in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Starna Therapeutics 48
Large-scale testing (Phase 3)Looking for participantsNCT06866405
What this trial is testing

Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose

Who this might be right for
RSV Infection
Pfizer 550
Not applicableStudy completedNCT05794412
What this trial is testing

Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study

Who this might be right for
SARS-CoV-2 InfectionInfluenza Viral InfectionsVirus Shedding+2 more
University Hospital, Geneva 320
Testing effectiveness (Phase 2)Study completedNCT03332459
What this trial is testing

A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Research & Development, LLC 7
Large-scale testing (Phase 3)Looking for participantsNCT07232706
What this trial is testing

Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination

Who this might be right for
RSV Immunization
Centre Hospitalier Annecy Genevois 1,000
Testing effectiveness (Phase 2)Study completedNCT02254408
What this trial is testing

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

Who this might be right for
Respiratory Syncytial Virus
Gilead Sciences 189
Testing effectiveness (Phase 2)Study completedNCT03303625
What this trial is testing

Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of Age

Who this might be right for
Respiratory Syncytial VirusesRespiratory Tract Infections
Janssen Vaccines & Prevention B.V. 48
Testing effectiveness (Phase 2)Study completedNCT04071158
What this trial is testing

A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

Who this might be right for
Respiratory Tract Infection
Pfizer 713
Next Page